Table 2.
Mean intensity of JUNB, CXCR4, TYROBP, PRDX1, NFYA, and YWHAB in breast cancer cell lines, PBMCs, and CTCs
| Mean intensity | Normal PBMCs | Patients PBMCs | SKBR3 | MCF7 | MDA-MB 231 | Hela | Int CTCs |
|---|---|---|---|---|---|---|---|
| JUNB | 5.2 ± 0.15 | 4.4 ± 0.11 | 26.1 ± 1.8 | 8.9 ± 0.56 | 6.6 ± 0.15 | 6.2 ± 0.65 | 9.6 ± 6.3 |
| CXCR4 | 10.62 ± 1.01 | 25.4 ± 1.59 | 168.8 ± 8.25 | 13.86 ± 0.51 | 10.22 ± 0.7 | 26.85 ± 2.69 | 33.57 ± 9.25 |
| TYROBP | 5.17 ± 0.67 | 4.82 ± 0.21 | 3.97 ± 0.13 | 3.61 ± 0.1 | 5.08 ± 0.09 | 3.49 ± 0.24 | 8.89 ± 3.53 |
| PRDX1 | 15.9 ± 3.62 | 34.73 ± 9.69 | 3.53 ± 0.22 | 6.25 ± 0.18 | 22.01 ± 1.64 | 4.83 ± 0.00 | 29.34 ± 24.65 |
| NFYA | 5.91 ± 0.52 | 6.08 ± 0.25 | 3.95 ± 0.23 | 4.93 ± 0.09 | 7.26 ± 0.15 | 5.41 ± 0.18 | 5.20 ± 1.36 |
| YWHAB | 26.13 ± 10.10 | 0 ± 0 | 4.04 ± 0.15 | 7.60 ± 0.12 | 26.45 ± 3.52 | 8.20 ± 0.4 | 5.70 ± 0.28 |